Hitosugi Masahito, Mukaisho Kenichi, Kido Masahito, Kamimura Shuichi, Furukawa Satoshi, Sugihara Hiroyuki
Department of Legal Medicine, Shiga University of Medical Science.
Department of Pathology, Shiga University of Medical Science.
Biomed Res. 2017;38(5):307-312. doi: 10.2220/biomedres.38.307.
Although the morbidity rate of prostate cancer has increased with 2.3 times in these 10 years in Japan, little is known about the changes in the prevalence of latent prostate cancer. To understand changes in the prevalence of latent prostate cancer, a retrospective analysis was performed. Forensic autopsy findings from Tochigi Prefecture between September 2012 and February 2014 were collected. Two cross sections, from the base and apex of the prostate, were examined histopathologically. The prevalence of latent prostate cancer was compared with findings from forensic autopsies performed between August 2002 and July 2005 in the same region. The prevalence of latent prostate cancer in both groups was similar, showing an overall prevalence of 13.6% and 12.2% and a Gleason score >6 of 6.2% and 7.1%, respectively. When prevalence was compared by cause of death, the values were similar for both groups. The prevalence of latent prostate cancer in this Japanese population did not show any significant change over the past 10 years. The dramatic increase in morbidity rate for prostate cancer could be from the increase in prostate-specific antigen screening and subsequent referral to urologists.
尽管在过去10年里日本前列腺癌的发病率增长了2.3倍,但关于潜伏性前列腺癌患病率的变化却知之甚少。为了解潜伏性前列腺癌患病率的变化,我们进行了一项回顾性分析。收集了2012年9月至2014年2月期间枥木县的法医尸检结果。对前列腺底部和顶部的两个横断面进行了组织病理学检查。将潜伏性前列腺癌的患病率与2002年8月至2005年7月在同一地区进行的法医尸检结果进行了比较。两组潜伏性前列腺癌的患病率相似,总体患病率分别为13.6%和12.2%,Gleason评分>6的分别为6.2%和7.1%。按死因比较患病率时,两组的值相似。在过去10年里,日本人群中潜伏性前列腺癌的患病率没有显示出任何显著变化。前列腺癌发病率的急剧上升可能源于前列腺特异性抗原筛查的增加以及随后转诊至泌尿科医生。